(Q61781881)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Recombinant apolipoproteins for the treatment of vascular diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Guido Franceschini

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

C R Sirtori

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

29-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

Identification of apolipoprotein A1 and immunoglobulin as components of a serum complex that mediates activation of human sperm motility.

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

High-density lipoprotein--the clinical implications of recent studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

The amino acid sequence of human Apoa-I, an apolipoprotein isolated from high density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Structural models of human apolipoprotein A-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Carboxyl-terminal domain truncation alters apolipoprotein A-I in vivo catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Structural studies of a peptide activator of human lecithin-cholesterol acyltransferase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Branched synthetic constructs that mimic the physico-chemical properties of apolipoprotein AI in reconstituted high-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Activation of Lecithin Cholesterol Acyltransferase by a Disulfide-Linked Apolipoprotein A-I Dimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Isolation and characterization of apolipoproteins A-I, A-II, and A-IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Isolation and characterization of apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

A purification method for apolipoprotein A-I and A-II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Production and characterization of a reconstituted high density lipoprotein for therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

The role of apolipoprotein AI domains in lipid binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Effects of deletion of the carboxyl-terminal domain of ApoA-I or of its substitution with helices of ApoA-II on in vitro and in vivo lipoprotein association.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Deletion of central alpha-helices in human apolipoprotein A-I: effect on phospholipid association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Alterations of the glutamine residues of human apolipoprotein AI propeptide by in vitro mutagenesis. Characterization of the normal and mutant protein forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Physical and chemical characteristics of apolipoprotein A-I-lipid complexes produced by Chinese hamster ovary cells transfected with the human apolipoprotein A-I gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Expression of the human apolipoprotein AI gene fused to the E. coli gene for beta-galactosidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Expression of recombinant human apolipoprotein A-I in Chinese hamster ovary cells and Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Production of human recombinant proapolipoprotein A-I in Escherichia coli: purification and biochemical characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Production of authentic human proapolipoprotein A-I in Escherichia coli: strategies for the removal of the amino-terminal methionine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Structural and functional properties of full-length and truncated human proapolipoprotein AI expressed in escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Mature apolipoprotein AI and its precursor proApoAI: influence of the sequence at the 5' end of the gene on the efficiency of expression in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Characterization of human apolipoprotein A-I expressed in Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Correct in vivo processing of a chimeric ubiquitin-proapolipoprotein A-I fusion protein in baculovirus-infected insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Production of mature human apolipoprotein A-I in a baculovirus-insect cell system: propeptide is not essential for intracellular processing but may assist rapid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

High-level secretion of human apolipoprotein E produced in Escherichia coli: use of a secretion plasmid containing tandemly polymerized ompF-hybrid gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Baculovirus-mediated expression of human apolipoprotein E in Manduca sexta larvae generates particles that bind to the low density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Effects of intravenous infusion of lipid-free apo A-I in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by electron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Reconstitution of high-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Interactions of dipalmitoyl- and dimyristoylphosphatidylcholines and their mixtures with apolipoprotein A-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein A-I conformation in discoidal particles: evidence for alternate structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Drug control of reverse cholesterol transport.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Reconstituted high-density lipoprotein reduces LPS-stimulated TNF alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Exogenous supply of artificial lipoproteins does not decrease susceptibility to atherosclerosis in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in vivo gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Can we really grow new blood vessels?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Toward the quiescent coronary plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Prevention of restenosis future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Imaging the left anterior descending coronary artery by high-frequency transthoracic echocardiography in heart transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Visualization of the coronary arteries in three-dimensional reconstructions using respiratory gated magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Apolipoprotein function in health and disease: insights from natural mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Reconstituted high density lipoprotein modulates adherence of polymorphonuclear leukocytes to human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900247-0

10.1016/S0021-9150(98)00247-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9920503%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference